These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22523216)

  • 1. Performance evaluation of new automated hepatitis B viral markers in the clinical laboratory: two quantitative hepatitis B surface antigen assays and an HBV core-related antigen assay.
    Park Y; Hong DJ; Shin S; Cho Y; Kim HS
    Am J Clin Pathol; 2012 May; 137(5):770-7. PubMed ID: 22523216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fundamental and clinical evaluation of hepatitis B virus core-related antigen assay by LUMIPULSE f].
    Tanaka Y; Takagi K; Hiramatsu K; Naganuma H; Iida T; Takasaka Y; Mizokami M
    Rinsho Byori; 2006 Jul; 54(7):692-8. PubMed ID: 16913659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantation.
    Matsuzaki T; Tatsuki I; Otani M; Akiyama M; Ozawa E; Miuma S; Miyaaki H; Taura N; Hayashi T; Okudaira S; Takatsuki M; Isomoto H; Takeshima F; Eguchi S; Nakao K
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1217-22. PubMed ID: 23432697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.
    Ronsin C; Pillet A; Bali C; Denoyel GA
    J Clin Microbiol; 2006 Apr; 44(4):1390-9. PubMed ID: 16597867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantification.
    Yeh ML; Huang CF; Hsieh MY; Huang JF; Dai CY; Yu ML; Chuang WL
    J Clin Virol; 2014 Jul; 60(3):206-14. PubMed ID: 24809730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
    Tanaka E; Matsumoto A; Yoshizawa K; Maki N
    Intervirology; 2008; 51 Suppl 1():3-6. PubMed ID: 18544941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B.
    Seto WK; Wong DK; Fung J; Huang FY; Liu KS; Lai CL; Yuen MF
    Clin Microbiol Infect; 2014 Nov; 20(11):1173-80. PubMed ID: 24975365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
    Suzuki F; Miyakoshi H; Kobayashi M; Kumada H
    J Med Virol; 2009 Jan; 81(1):27-33. PubMed ID: 19031469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
    Launay O; Masurel J; Servant-Delmas A; Basse-Guérineau AL; Méritet JF; Laperche S; Sogni P; Rosenberg AR
    J Viral Hepat; 2011 Oct; 18(10):721-9. PubMed ID: 21914087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres.
    Congly SE; Wong P; Al-Busafi SA; Doucette K; Fung SK; Ghali P; Fonseca K; Myers RP; Osiowy C; Coffin CS
    Liver Int; 2013 Oct; 33(9):1363-9. PubMed ID: 23763288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.
    Wursthorn K; Jaroszewicz J; Zacher BJ; Darnedde M; Raupach R; Mederacke I; Cornberg M; Manns MP; Wedemeyer H
    J Clin Virol; 2011 Apr; 50(4):292-6. PubMed ID: 21273117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers.
    Xun YH; Zang GQ; Guo JC; Yu XL; Liu H; Xiang J; Liu J; Shi JP
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1746-55. PubMed ID: 23800140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Abbott Architect i2000 assay, the Roche Modular Analytics E170 assay, and an immunoradiometric assay for serum hepatitis B virus markers.
    Kim H; Oh EJ; Kang MS; Kim SH; Park YJ
    Ann Clin Lab Sci; 2007; 37(3):256-9. PubMed ID: 17709690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
    Weber B
    Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.
    Moerman B; Moons V; Sommer H; Schmitt Y; Stetter M
    Clin Lab; 2004; 50(3-4):159-62. PubMed ID: 15074469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.
    Rokuhara A; Tanaka E; Matsumoto A; Kimura T; Yamaura T; Orii K; Sun X; Yagi S; Maki N; Kiyosawa K
    J Viral Hepat; 2003 Jul; 10(4):324-30. PubMed ID: 12823601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution.
    Liu TW; Yeh ML; Huang CF; Lin IL; Huang JF; Dai CY; Chen YL; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2015 Jan; 31(1):26-33. PubMed ID: 25600917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.